Lovelace Biomedical is a not-for-profit preclinical contract research organization that specializes in advancing biomedical science through comprehensive nonclinical and clinical research. The organization offers a wide range of services, including toxicology, bioanalytical and analytical chemistry, pharmacokinetics, pharmacology, and formulation development. Their expertise extends to various specialty areas such as respiratory diseases, infectious diseases, gene therapy, and medical countermeasures. Lovelace Biomedical prides itself on its ability to provide personalized service and rapid adaptability to client needs, leveraging a multidisciplinary approach to enhance the understanding of disease biology and drug development processes.

The facilities at Lovelace Biomedical are equipped with state-of-the-art laboratories and high-containment environments, including ABSL3-enhanced laboratory space and specialized animal housing. Their infrastructure supports a variety of research programs, from gene therapies to infectious disease solutions, and is compliant with FDA Good Laboratory Practice regulations. The organization emphasizes a commitment to scientific integrity, investing in cutting-edge technologies and maintaining a streamlined operational structure that facilitates quick turnaround times for proposals and contracts. This unique combination of expertise, facilities, and a client-focused approach positions Lovelace Biomedical as a leader in the preclinical research landscape.

United States

Lovelace Biomedical is a biomedical research company that provides preclinical services to the pharmaceutical industry.

Lovelace Biomedical

Company Details